Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study
L. Boschung-Pasquier(University of Bern), Baharak Babouee Flury(University of Bern), Yok‐Ai Que(University Hospital of Lausanne), Dominique I. Furrer(University of Bern), Sarah Banholzer(University of Bern), Christine Hauser(Monash University), Manuel Haschke(University of Bern), Niccolò Buetti(University of Geneva), Philipp Jent(University of Bern), A. Atkinson(University of Bern), Hansjakob Furrer(University of Bern), Lucas Kastner(University of Bern)
Cited by 143
Related Papers
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey
|Journal of Critical Care|2020|350
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
|British Journal of Cancer|2010|301
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
|Intensive Care Medicine|2023|257
Coordinated Regulation of Insulin Signaling by the Protein Tyrosine Phosphatases PTP1B and TCPTP
|Molecular and Cellular Biology|2005|210